This study has extended previous metabolic measures in postmortem tissues (frontal and parietal lobes, pons, cerebellum, hippocampus, and cerebral cortex) obtained from a 37-year-old male patient with
succinic semialdehyde dehydrogenase deficiency (SSADHD) who expired from
SUDEP (sudden unexplained death in
epilepsy). Histopathologic characterization of fixed cortex and hippocampus revealed mild to moderate
astrogliosis, especially in white matter. Analysis of total
phospholipid mass in all sections of the patient revealed a 61% increase in cortex and 51% decrease in hippocampus as compared to (n = 2-4) approximately age-matched controls. Examination of mass and molar composition of major
phospholipid classes showed decreases in
phospholipids enriched in myelin, such as
phosphatidylserine,
sphingomyelin, and
ethanolamine plasmalogen. Evaluation of gene expression (RT2 Profiler PCR Arrays,
GABA,
glutamate; Qiagen) revealed dysregulation in 14/15 GABAA receptor subunits in cerebellum, parietal, and frontal lobes with the most significant downregulation in ∊, θ, ρ1, and ρ2 subunits (7.7-9.9-fold). GABAB receptor subunits were largely unaffected, as were
ionotropic glutamate receptors. The
metabotropic glutamate receptor 6 was consistently downregulated (maximum 5.9-fold) as was the
neurotransmitter transporter (GABA), member 13 (maximum 7.3-fold). For other genes, consistent dysregulation was seen for
interleukin 1β (maximum downregulation 9.9-fold) and
synuclein α (maximal upregulation 6.5-fold). Our data provide unique insight into SSADHD brain function, confirming
astrogliosis and
lipid abnormalities previously observed in the null mouse model while highlighting long-term effects on GABAergic/glutamatergic gene expression in this disorder.